Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0300
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST
Firebrick Pharma Revenue
In the fiscal year ending June 30, 2026, Firebrick Pharma had annual revenue of 135.62K AUD, down -73.69%. Firebrick Pharma had revenue of 43.36K in the half year ending June 30, 2026, a decrease of -95.36%.
Revenue
135.62K
Revenue Growth
-73.69%
P/S Ratio
63.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 135.62K | -379.89K | -73.69% |
| Jun 30, 2025 | 515.51K | -2.23M | -81.26% |
| Jun 30, 2024 | 2.75M | 2.73M | 12,096.48% |
| Jun 30, 2023 | 22.55K | -1.06M | -97.92% |
| Jun 30, 2022 | 1.08M | 661.35K | 156.72% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.58B |
| Sigma Healthcare | 10.83B |
| Pro Medicus | 261.69M |
| Adheris Health | 33.96M |
| ECS Botanics Holdings | 21.02M |
| Cann Group | 9.65M |
| Careteq | 6.08M |